芒果视频下载

成立于1997年，國內造影劑仿制藥產品中規模大/品種齊全的工廠，旗下上海司太立生產碘帕醇注射液/碘海醇注射液和碘克沙醇注射液等造影劑產品

浙江(jiang)司(si)(si)太(tai)(tai)(tai)立(li)(li)制(zhi)(zhi)藥(yao)(yao)股份有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)成(cheng)立(li)(li)于1997年(nian)(nian)，是一(yi)家專門從(cong)事研發、生產(chan)、銷售X-CT非(fei)離(li)子型(xing)造影劑系列(lie)和(he)喹(kui)諾酮類系列(lie)原(yuan)料(liao)藥(yao)(yao)及中間體的(de)高新技術企業(ye)，是國內造影劑仿(fang)制(zhi)(zhi)藥(yao)(yao)產(chan)品(pin)(pin)中規模(mo)大、品(pin)(pin)種齊全的(de)工廠。“十(shi)二五”期間，公(gong)(gong)(gong)(gong)司(si)(si)向(xiang)產(chan)業(ye)鏈的(de)前(qian)端和(he)末端延伸，于2011年(nian)(nian)1月(yue)在江(jiang)西(xi)樟樹建立(li)(li)中間體生產(chan)基地——江(jiang)西(xi)司(si)(si)太(tai)(tai)(tai)立(li)(li)制(zhi)(zhi)藥(yao)(yao)有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)，于2012年(nian)(nian)6月(yue)在上海金山(shan)建立(li)(li)制(zhi)(zhi)劑工廠——上海司(si)(si)太(tai)(tai)(tai)立(li)(li)制(zhi)(zhi)藥(yao)(yao)有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)。2016年(nian)(nian)3月(yue)9日，公(gong)(gong)(gong)(gong)司(si)(si)在上海證券交易所(suo)上市，股票(piao)代碼：603520。2018年(nian)(nian)11月(yue)，公(gong)(gong)(gong)(gong)司(si)(si)成(cheng)功收購國內同(tong)行(xing)企業(ye)——浙江(jiang)臺州(zhou)海神制(zhi)(zhi)藥(yao)(yao)有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)，邁(mai)入高速發展的(de)快車道。

在過去的(de)二(er)十(shi)多年里，公(gong)司(si)(si)始終保持良好穩(wen)定的(de)發(fa)展勢頭，成為(wei)國(guo)(guo)內(nei)(nei)X-CT非離子型造影劑原(yuan)料(liao)(liao)藥(yao)(yao)(yao)龍(long)頭企業(ye)。其(qi)中(zhong)(zhong)，碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)原(yuan)料(liao)(liao)藥(yao)(yao)(yao)產(chan)(chan)(chan)能及產(chan)(chan)(chan)量位(wei)(wei)居國(guo)(guo)內(nei)(nei)首位(wei)(wei)。公(gong)司(si)(si)產(chan)(chan)(chan)品質量穩(wen)定，并取得(de)(de)(de)(de)多個發(fa)達國(guo)(guo)家(jia)認證(zheng)(zheng)(zheng)。公(gong)司(si)(si)生(sheng)產(chan)(chan)(chan)的(de)原(yuan)料(liao)(liao)藥(yao)(yao)(yao)碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)帕(pa)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)克(ke)沙(sha)(sha)醇(chun)(chun)(chun)、左(zuo)氧氟沙(sha)(sha)星(xing)(xing)(xing)、鹽酸左(zuo)氧氟沙(sha)(sha)星(xing)(xing)(xing)獲(huo)(huo)得(de)(de)(de)(de)國(guo)(guo)家(jia)藥(yao)(yao)(yao)品GMP證(zheng)(zheng)(zheng)書；原(yuan)料(liao)(liao)藥(yao)(yao)(yao)碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)帕(pa)醇(chun)(chun)(chun)獲(huo)(huo)得(de)(de)(de)(de)歐盟CEP證(zheng)(zheng)(zheng)書；原(yuan)料(liao)(liao)藥(yao)(yao)(yao)碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)帕(pa)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)克(ke)沙(sha)(sha)醇(chun)(chun)(chun)、左(zuo)氧氟沙(sha)(sha)星(xing)(xing)(xing)、鹽酸左(zuo)氧氟沙(sha)(sha)星(xing)(xing)(xing)獲(huo)(huo)得(de)(de)(de)(de)國(guo)(guo)內(nei)(nei)注冊批件；原(yuan)料(liao)(liao)藥(yao)(yao)(yao)碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)帕(pa)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)克(ke)沙(sha)(sha)醇(chun)(chun)(chun)、左(zuo)氧氟沙(sha)(sha)星(xing)(xing)(xing)獲(huo)(huo)得(de)(de)(de)(de)印(yin)度注冊批件；原(yuan)料(liao)(liao)藥(yao)(yao)(yao)碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)、碘(dian)(dian)(dian)(dian)(dian)(dian)帕(pa)醇(chun)(chun)(chun)、左(zuo)氧氟沙(sha)(sha)星(xing)(xing)(xing)、洛索洛芬(fen)鈉和中(zhong)(zhong)間體左(zuo)氧環合酯獲(huo)(huo)得(de)(de)(de)(de)日(ri)本登錄證(zheng)(zheng)(zheng)。目前(qian)，獲(huo)(huo)得(de)(de)(de)(de)歐盟CEP證(zheng)(zheng)(zheng)書的(de)全(quan)球碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)原(yuan)料(liao)(liao)藥(yao)(yao)(yao)生(sheng)產(chan)(chan)(chan)廠家(jia)有(you)4家(jia)，中(zhong)(zhong)國(guo)(guo)僅司(si)(si)太立（含海(hai)神制藥(yao)(yao)(yao)）一家(jia)；獲(huo)(huo)得(de)(de)(de)(de)日(ri)本登錄證(zheng)(zheng)(zheng)的(de)全(quan)球碘(dian)(dian)(dian)(dian)(dian)(dian)海(hai)醇(chun)(chun)(chun)原(yuan)料(liao)(liao)藥(yao)(yao)(yao)生(sheng)產(chan)(chan)(chan)廠家(jia)有(you)4家(jia)，司(si)(si)太立（含海(hai)神制藥(yao)(yao)(yao)）亦是其(qi)中(zhong)(zhong)之一。

在喹(kui)諾酮類系(xi)列(lie)原料藥方面，公(gong)司在左氧氟沙星(xing)系(xi)列(lie)產(chan)品雜(za)質分離及合成(cheng)領域處于國(guo)內領先水(shui)平，是(shi)國(guo)內產(chan)量較大的左氧氟沙星(xing)系(xi)列(lie)生產(chan)企業(ye)之一。

公(gong)(gong)司(si)著眼于X射線(xian)造影(ying)劑(ji)的(de)(de)可持(chi)續發展戰略，高度重視自(zi)主研發能力，并取得(de)了豐碩的(de)(de)成果(guo)。公(gong)(gong)司(si)是浙(zhe)江(jiang)省(sheng)企業技術(shu)(shu)中心(xin)和浙(zhe)江(jiang)省(sheng)非離子型(xing)造影(ying)劑(ji)高新技術(shu)(shu)研究中心(xin)。公(gong)(gong)司(si)承擔的(de)(de)“非離子型(xing)X-CT造影(ying)劑(ji)原料藥—碘海醇”項目(mu)和“第四代喹諾酮類抗菌藥物(wu)關鍵中間(jian)體帕(pa)珠(zhu)沙星產業化”項目(mu)均獲得(de)了由中華人民(min)共和國(guo)科學技術(shu)(shu)部火炬高技術(shu)(shu)產業開(kai)發中心(xin)頒發的(de)(de)“國(guo)家(jia)火炬計(ji)劃項目(mu)證書”。原料藥碘海醇和帕(pa)珠(zhu)沙星還被(bei)浙(zhe)江(jiang)省(sheng)科學技術(shu)(shu)廳評(ping)定為“浙(zhe)江(jiang)省(sheng)高新技術(shu)(shu)產品”。

2020年，公司(si)(si)(si)旗下全資子公司(si)(si)(si)上海司(si)(si)(si)太(tai)立制(zhi)藥(yao)(yao)有限公司(si)(si)(si)申報的碘帕醇注(zhu)射(she)液、碘海醇注(zhu)射(she)液和碘克(ke)沙(sha)醇注(zhu)射(she)液等產品通(tong)(tong)過(guo)(guo)國(guo)家新4類注(zhu)冊（視同通(tong)(tong)過(guo)(guo)“藥(yao)(yao)物(wu)一致(zhi)性評價”），獲(huo)得(de)國(guo)家藥(yao)(yao)品監督管理局的注(zhu)冊批(pi)件。上海司(si)(si)(si)太(tai)立制(zhi)藥(yao)(yao)有限公司(si)(si)(si)補充(chong)了(le)(le)司(si)(si)(si)太(tai)立制(zhi)藥(yao)(yao)產業鏈在制(zhi)劑部分的空白，使公司(si)(si)(si)成功地(di)完成了(le)(le)從原料藥(yao)(yao)向制(zhi)劑拓展的產業轉(zhuan)型升級。

公司(si)以“聚合生命能量，呵護人類健康(kang)”為(wei)經(jing)營理念，不斷豐(feng)富X射線造影劑系列產(chan)品，公司(si)將力爭(zheng)成為(wei)中國(guo)乃至全(quan)球知名的醫藥企業。